BIOSYENT
BioSyent is one of Canada’s fastest growing independent pharmaceutical companies registering a compound annual growth rate (CAGR) in sales of 56% during the three year period ending 2014. It is focused on commercializing products that provide a distinguishable benefit to patients and their healthcare providers and is known for its ability to effectively and efficiently introduce new products to the Canadian market. BioSyent is actively sought out as the Canadian market partner of choice by brand innovators with niche or specialty products looking for a trusted partner.
BIOSYENT
Industry:
Pharmaceutical
Founded:
1947-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.biosyent.com
Total Employee:
11+
Status:
Active
Contact:
905.206.0013
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Domain Not Resolving Nginx Microsoft Exchange Online Office 365 Mail
Similar Organizations
Biomedicina
Biomedicina is a pharmaceutical company.
Bionavigen
Bionavigen is a biopharmaceutical company.
Ileo Science
Ileo Science is a Pharmaceutical company.
Integrum Scientific
Integrum Scientific is a pharmaceuticals company.
My Med Center
MyMed.Center is a network pharma company.
PatientCentra
PatientCentra is a Pharmaceuticals company.
SynP4
SynP4 is a Pharmaceutical company
Stock Details
Official Site Inspections
http://www.biosyent.com Semrush global rank: 5.91 M Semrush visits lastest month: 1.4 K
- Host name: cloudproxy10157.sucuri.net
- IP address: 192.124.249.157
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BioSyent"
BioSyent
BioSyent is a profitable and growing specialty pharmaceutical company committed to improving the lives of patients with unique and effective products in Canada and select international …See details»
About BioSyent
About BioSyent. Listed on the TSX Venture Exchange (TSXV: RX), BioSyent is a profitable growth oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical products that have been …See details»
Investors - BioSyent
Sep 30, 2024 2023 marked BioSyent’s 14th consecutive year of profitability. During 2023, BioSyent launched new products in Canada as it continued to execute on its strategic priorities of profitable growth, portfolio diversification …See details»
BioSyent - Crunchbase Company Profile & Funding
BioSyent is one of Canada’s fastest growing independent pharmaceutical companies registering a compound annual growth rate (CAGR) in sales of 56% during the three year period ending …See details»
BioSyent Inc - BioSyent Inc - LinkedIn
BioSyent is one of Canada’s fastest growing independent pharmaceutical companies registering a compound annual growth rate (CAGR) of 70% during the three year period ending 2012. It is …See details»
BioSyent Inc. - AnnualReports.com
Listed on the TSX Venture Exchange (TSXV: RX) BioSyent is a profitable growth oriented speciality pharmaceutical company which searches the globe to in-license or acquire …See details»
BioSyent - businessabc.net
Nov 21, 2024 BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and …See details»
BioSyent Inc Company Profile | Mississauga, ON, Canada
Find company research, competitor information, contact details & financial data for BioSyent Inc of Mississauga, ON. Get the latest business insights from Dun & Bradstreet.See details»
BioSyent Inc - LinkedIn
BioSyent Inc | 1,929 followers on LinkedIn. Listed on the TSX Venture Exchange (TSXV: RX) BioSyent is a profitable growth oriented speciality pharmaceutical company which searches …See details»
About - BioSyent
©2024 All rights reserved. BioSyent Inc. BioSyent Pharma Inc. About; Products; Investors; Careers; News; Contact; English; FrançaisSee details»
BioSyent - Contacts, Employees, Board Members, Advisors & Alumni
BioSyent has 1 current employee profile, Chairman, President & Chief Executive Officer René C. Goehrum. René C. Goehrum Chairman, President & Chief Executive Officer Unlock even …See details»
BioSyent Company Profile - Office Locations, Competitors ... - Craft
BioSyent is a pharmaceutical company focused on in-licensing or acquiring pharmaceutical products. Its products include FeraMAX 150, an oral hematinic for the prevention and …See details»
BioSyent Inc. (BIOYF) Company Profile & Overview - Stock Analysis
Oct 2, 2024 The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to …See details»
FAX Capital Files Early Warning Report Regarding Disposition of …
3 hours ago BioSyent is a publicly traded specialty pharmaceutical company which, through its wholly owned subsidiaries, BioSyent Pharma Inc. and BioSyent Pharma International Inc., …See details»
BioSyent - Overview, News & Similar companies | ZoomInfo.com
BioSyent Declares Third Quarter 2024 Dividend MISSISSAUGA, Ontario, Aug. 26, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to …See details»
Contact - BioSyent
This field is for validation purposes and should be left unchanged. ©2024 All rights reserved. BioSyent Inc. BioSyent Pharma Inc.See details»
Company BioSyent Inc. - MarketScreener.com
May 31, 1999 BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., …See details»
Board of Directors - BioSyent
Ms. Elford is a Corporate Director who brings a wealth of capital markets and corporate governance experience to the Board. In addition to BioSyent, she is a member of the Board of …See details»
Virtual Event Services
I give consent to BioSyent Inc. to send commercial and clinical electronic communications; including, but not limited to, news, learning events, product, and therapeutic information.* YesSee details»
News - BioSyent
Dec 16, 2024 On the eve of International Women’s Day, BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) celebrates the Canadian launch of FeraMAX® Pd Maintenance …See details»